BTC of New Bedford /ID# 226289 — New Bedford, Massachusetts

BTC of New Bedford /ID# 226289 is a clinical research site located in New Bedford, Massachusetts, United States 02740.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

BTC of New Bedford /ID# 226289 has participated in 1 clinical trials.

Therapeutic areas: Episodic Migraine, Chronic Migraine.

Sponsors: AbbVie.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for BTC of New Bedford /ID# 226289?

BTC of New Bedford /ID# 226289 has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has BTC of New Bedford /ID# 226289 conducted?

BTC of New Bedford /ID# 226289 has 1 clinical trials on record. Their work covers Episodic Migraine, Chronic Migraine.

Is BTC of New Bedford /ID# 226289 accredited by Crixeo Health?

BTC of New Bedford /ID# 226289 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about BTC of New Bedford /ID# 226289?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.